Total Visits

Views
Long-term survivors with advanced non-squamous non-small cell lung cancer (NSNSCLC) treated with first-line (1l) chemotherapy (CT) plus bevacizumab (B) and maintenance (MTC) B32

Select a period of time:

Views

Views
October 20250
November 20250
December 20251
January 20260
February 20260
March 20260
April 20260
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore1
 

Top cities views

Views